UroChat
SUNA’s Webinar Series
September 15 - The First and Only FDA-Approved Medication for Adult Patients With Recurrent LG-IR-NMIBC
Join SUNA and UroGen Pharma for an educational presentation focused on an FDA-approved medication for adult patients with recurrent low-grade, intermediate-risk non-muscle invasive bladder cancer, also known as LG-IR-NMIBC.The presentation will be led by Nazy Zomorodian, MSN, CUNP, an experienced nurse practitioner, clinical research leader, and educator specializing in urologic oncology.
Sponsored by
Presenter: Nazy Zomorodian, MSN, CUNP, David Geffen School of Medicine, Institute of Urologic Oncology at UCLA
Nazy Zomorodian is Director of the Genitourinary Clinical Trials Unit and an Associate Professor and Nurse Practitioner in the Department of Urology. She received her Bachelor of Science and Master of Science in Nursing from Hahnemann University in Philadelphia and is pursuing a Ph.D. in Research Nursing at UCLA.Ms. Zomorodian is certified by the Association of Clinical Research Professionals as a Clinical Research Coordinator and is a certified nurse practitioner in both urology and oncology. She has extensive experience managing and conducting cancer research and has worked closely with UCLA’s urologic and medical oncology principal investigators in basic research for more than 20 years.She regularly instructs physicians, fellows, residents, and nurses on all aspects of clinical trials for kidney, prostate, and bladder cancers.
The September 15 presentation is sponsored by UroGen Pharma. The content and information presented during this program are provided for educational purposes. Please refer to the applicable full prescribing information for complete product information.
UroChat, SUNA’s new webinar series, was developed to provide engaging discussion on a variety of topics for all levels in the urology field. This webinar series allows members to engage with speakers and other members across the county through presentations and open dialogue. This is a complimentary benefit to SUNA members.
UroChat sessions have featured expert-led discussions on clinical guidelines, patient care strategies, and emerging trends in urology. Some recent topics include:
Renal Mass Guidelines and Updates
Medical Malpractice for Nurses
MA Standards: A SUNA Position Statement
Let's Talk about Men's Health and Erectile Dysfunction
BPH Update: Meds and Beyond
Medication for Managing Renal Stone Disease
Men’s Health & Prostate Cancer
